Case Studies
Instylla HES Hypervascular Tumor Study
A variety of tumors in the liver, kidney, and bone were treated on the Instylla HES Hypervascular Tumor Study. Presented below is a limited selection of cases where Embrace HES was used.
Hepatocellular Carcinoma
Transarterial Embolization for Unresectable HCC
A 64-year-old female was diagnosed with a 2.1 cm focal, encapsulated hepatocellular carcinoma (HCC) located in Segment VIII of the liver. The tumor was unilobar, and the patient was considered unsuitable for surgical resection. Based on multidisciplinary evaluation, the decision was made to proceed with liver-directed therapy using TAE.
Liver Metastasis
Transarterial Embolization for Liver Metastasis from Breast Cancer
A 43-year-old female, originally diagnosed with breast cancer, underwent mastectomy followed by multiple systemic chemotherapy regimens. Five years from diagnosis, imaging identified a new, solitary, unresectable metastatic lesion in Segment V of the liver. The patient was referred for embolization as a liver-directed therapy.
Angiomyolipoma
Transarterial Embolization for Renal Angiomyolipoma
A 60-year-old female presented with a right renal angiomyolipoma measuring 4.6 cm. The lesion was focal, encapsulated, and considered appropriate for embolization to achieve tumor control and prevent future complications.
Bone Metastasis
Preoperative Embolization of Acetabular Bone Metastasis
A 70-year-old female with a history of renal cell carcinoma and prior radiation presented with a symptomatic metastatic lesion in the left hip acetabulum. The lesion was ill-defined, osteolytic in nature, and measured 5.3 cm.
Primary Hepatocellular Carcinoma
Transarterial Embolization for Advanced HCC in a 69-year Old Male with prior therapies
A 69-year-old male with advanced HCC and prior systemic and locoregional treatments presented with a residual tumor in Segment V of the liver. The primary lesion measured 4.7 cm, was focal and encapsulated, with evidence of extrahepatic disease.